Back
Summit Therapeutics, Inc. 10K Form
Sell
46
SMMT
Summit Therapeutics, Inc.
Last Price:
$18.31
Seasonality Move:
26.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-07 | 10Q | SMMT/Summit Therapeutics, Inc. Quarterly |
| 2023-08-09 | 10Q | SMMT/Summit Therapeutics, Inc. Quarterly |
| 2023-05-11 | 10Q | SMMT/Summit Therapeutics, Inc. Quarterly |
| 2022-11-09 | 10Q | SMMT/Summit Therapeutics, Inc. Quarterly |
| 2022-08-11 | 10Q | SMMT/Summit Therapeutics, Inc. Quarterly |
| 2022-05-11 | 10Q | SMMT/Summit Therapeutics, Inc. Quarterly |
Receive SMMT News And Ratings
See the #1 stock for the next 7 days that we like better than SMMT
SMMT Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-95.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.26 |
| Price / Book: | 70.9 |
Profitability
| EPS (TTM): | -1.24180 |
|---|---|
| Net Income (TTM): | $-921.6M |
| Gross Margin: | $-89K |
| Return on Equity: | -283.98% |
| Return on Assets: | -241.51% |
Summit Therapeutics, Inc. Earnings Forecast
Key Summit Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 22 years have been positive in 10 years.
Summit Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SMMT |
| CUSIP: | 86627R |
| Website: | smmttx.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 3.8 |
| Quick Ratio: | 3.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SMMT Technical Analysis vs Fundamental Analysis
Sell
46
Summit Therapeutics, Inc. (SMMT)
is a Sell
Is Summit Therapeutics, Inc. a Buy or a Sell?
-
Summit Therapeutics, Inc. stock is rated a SellThe current Summit Therapeutics, Inc. [SMMT] share price is $18.31. The Score for SMMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.